Patents by Inventor Martin Munzer

Martin Munzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11688998
    Abstract: An emitter of electromagnetic radiation is configured for modes of operation providing fields of illumination of different widths, and a photodetector is configured for time-of-flight and proximity measurements by detecting electromagnetic radiation that is emitted by the emitter and reflected to the photodetector. The emitter is operated by a driver, which is configured for an alternation between the modes of operation. A time-of-flight measurement is performed when the field of illumination is narrow, and a proximity or ambient light measurement is performed when the field of illumination is wide.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: June 27, 2023
    Assignee: AMS AG
    Inventor: Martin Münzer
  • Patent number: 11652177
    Abstract: The semiconductor device comprises an emitter of electromagnetic radiation, a photodetector enabling a detection of electromagnetic radiation of a specific wavelength, a filter having a passband including the specific wavelength, the filter being arranged on the photodetector, the emitter and/or the filter being electrically tunable to the specific wavelength, and a circuit configured to determine a time elapsed between emission and reception of a signal that is emitted by the emitter and then received by the photodetector.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: May 16, 2023
    Assignee: AMS AG
    Inventors: Martin Münzer, Peter Trattler
  • Publication number: 20220202757
    Abstract: Protein substitute products that furnish nutrients include amino acid compositions that include essential amino acids and non-essential amino acids in a preferred ratio, along with Vitamins, nutrients and botanicals provided as a food or beverage product that provides sustenance. Amino acids are provided in ratios and with other components to stimulate production of mitochondria in the cells and increase mitochondrial density in each cell type, including in particular muscle cells. Compositions may include simple and complex sugar producing carbohydrates to provide a short to medium energy source to the production of ATP by the mitochondria.
    Type: Application
    Filed: April 9, 2020
    Publication date: June 30, 2022
    Inventor: Martin Munzer
  • Publication number: 20210135023
    Abstract: The semiconductor device comprises an emitter of electromagnetic radiation, a photodetector enabling a detection of electromagnetic radiation of a specific wavelength, a filter having a passband including the specific wavelength, the filter being arranged on the photodetector, the emitter and/or the filter being electrically tunable to the specific wavelength, and a circuit configured to determine a time elapsed between emission and reception of a signal that is emitted by the emitter and then received by the photodetector.
    Type: Application
    Filed: July 27, 2018
    Publication date: May 6, 2021
    Inventors: Martin MÜNZER, Peter Trattler
  • Publication number: 20210003704
    Abstract: An emitter of electromagnetic radiation is configured for modes of operation providing fields of illumination of different widths, and a photodetector is configured for time-of-flight and proximity measurements by detecting electromagnetic radiation that is emitted by the emitter and reflected to the photodetector. The emitter is operated by a driver, which is configured for an alternation between the modes of operation. A time-of-flight measurement is performed when the field of illumination is narrow, and a proximity or ambient light measurement is performed when the field of illumination is wide.
    Type: Application
    Filed: December 3, 2018
    Publication date: January 7, 2021
    Inventor: Martin MÜNZER
  • Patent number: 10871448
    Abstract: A fluorescence lifetime sensor module comprises an opaque housing having a first chamber and a second chamber which are separated by a light barrier. An optical emitter is arranged in the first chamber and configured to emit through a first aperture. Emission of pulses of light of a specified wavelength is arranged to optically excite a fluorescent probe to be positioned in front of the sensor module. A detector is arranged in the second chamber and configured to detect through a second aperture received photons from the fluorescent probe. A measurement block is configured to determine respective difference values representative of an arrival time of one of the received photons with respect to the emission pulses. A histogram block is configured to accumulate the difference values in a histogram.
    Type: Grant
    Filed: October 4, 2017
    Date of Patent: December 22, 2020
    Assignee: AMS AG
    Inventor: Martin Münzer
  • Publication number: 20200041414
    Abstract: A fluorescence lifetime sensor module comprises an opaque housing having a first chamber and a second chamber which are separated by a light barrier. An optical emitter is arranged in the first chamber and configured to emit through a first aperture. Emission of pulses of light of a specified wavelength is arranged to optically excite a fluorescent probe to be positioned in front of the sensor module. A detector is arranged in the second chamber and configured to detect through a second aperture received photons from the fluorescent probe. A measurement block is configured to determine respective difference values representative of an arrival time of one of the received photons with respect to the emission pulses. A histogram block is configured to accumulate the difference values in a histogram.
    Type: Application
    Filed: October 4, 2017
    Publication date: February 6, 2020
    Inventor: Martin MÜNZER
  • Publication number: 20100293113
    Abstract: A method and system for tracking and providing compensation to distributors of a product by using a unique identification code to identify the product at the point of sale, the original customer, and/or the original distributor. A product and/or advertising materials for the product, bearing a unique product code, are provided to distributors. The customer provides the unique product code at the point of purchase of one or more products. The distributor, who promoted the sale of the products, is identified based on the unique product code. Compensation is provided to the distributor based on the number of products sold. The customer may be offered a discount based on the unique product code at the point of purchase.
    Type: Application
    Filed: May 15, 2007
    Publication date: November 18, 2010
    Applicant: Cygene Laboratories, Inc.
    Inventors: Martin Munzer, Peter J. Laurence, George MacEdon
  • Publication number: 20080195326
    Abstract: A method and system (100) for comprehensive knowledge-based genetic and other testing and for providing selective access to testing results (120) thereof. In particular, a method and system is provided for the personal, anonymous and confidential examination of the genetic profile of any gene or combination of genes and examining any mutations of such genes to assess the risk of developing a condition, such as a medical disease, or to identify personal characteristics and/or traits. Other data, such as chemical analysis, environmental, personal and family history of medical, behavioral, and other factors can be incorporated to generate a comprehensive knowledge-based assessment. The method and system also include features for providing secure confidential access to such assessments to third parties (160).
    Type: Application
    Filed: May 3, 2005
    Publication date: August 14, 2008
    Inventors: Martin Munzer, Keith Zucker, Eduard Peter-Shofen, Andrea Doescher
  • Publication number: 20050197305
    Abstract: The invention includes a reverse polarity 8-aminopurine substituted oligonucleotide hairpin (parallel-stranded hairpin) referred to herein as RP8AP hairpin. Application of the invention to a biological system in a disease state results in the possible interference with a disease causing agent in a number of potential ways, for example, through interference with DNA replication, thereby preventing production of virulent pathogens (for example virus and bacteria) by inhibition of DNA synthesis, through interference with DNA transcription, including by inhibition of production of critical mRNA transcripts necessary for production of proteins essential for microbial multiplication and disease expression, and through interference on the translational level, including by inactivation of synthesized mRNA transcripts used in propagation of the disease, thereby rendering them unable to be translated.
    Type: Application
    Filed: August 13, 2004
    Publication date: September 8, 2005
    Inventors: Martin Lopez, Martin Munzer, Ramon Eritja
  • Publication number: 20050089893
    Abstract: The invention sets forth parallel-stranded hairpins and parallel-stranded hairpins carrying a single strand target, the parallel-stranded hairpins containing 8-aminopurine residues and are able to bind a target molecule of interest due to specificity in the two-dimensional and three-dimensional structures of the parallel-stranded hairpins and parallel-stranded hairpins carrying a single strand target. The invention also relates to creation of a library of parallel-stranded hairpins and associated triplexes for use as aptamers, as well as methods of synthesis of parallel-stranded hairpins and use of the structures of the invention to detect and eliminate molecules of interest.
    Type: Application
    Filed: August 4, 2004
    Publication date: April 28, 2005
    Inventors: Martin Lopez, Martin Munzer, Ramon Eritja
  • Publication number: 20040137431
    Abstract: The invention provides a method of capturing the ribo-nucleic acid (RNA) specific to the West Nile Virus (WNV); specifically it relates to the target sequences within the WNV genome that can be used to capture the specific RNA material for identification and/or provide target regions for the use of specific probes that inhibit the reproduction of the WNV in vivo, in the form of a gene therapy drug.
    Type: Application
    Filed: November 3, 2003
    Publication date: July 15, 2004
    Inventors: Ramon Eritja, Martin Munzer, Martin J. Lopez
  • Publication number: 20040073259
    Abstract: The invention provides a method of treating a patient infected with any contaminant and/or with any biological/chemical warfare agent wherein the contaminant is other than a human hepatitis C virus, an HIV virus, or the human herpes virus comprising raising the core temperature of the patient and then returning the core temperature of the patient to normal at least one time. Preferably, the patient is an animal infected with an equine herpes virus, a contaminant that has caused an equine encephalitis infection, or a West Nile Virus.
    Type: Application
    Filed: August 26, 2003
    Publication date: April 15, 2004
    Inventor: Martin Munzer